Geneva Advisors’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-7,433
| Closed | -$491K | – | 807 |
|
|
2016
Q3 | $491K | Sell |
7,433
-56
| -0.7% | -$3.7K | 0.01% | 470 |
|
|
2016
Q2 | $425K | Sell |
7,489
-4,555
| -38% | -$258K | 0.01% | 477 |
|
|
2016
Q1 | $702K | Buy |
12,044
+28
| +0.2% | +$1.63K | 0.01% | 361 |
|
|
2015
Q4 | $707K | Sell |
12,016
-26,148
| -69% | -$1.54M | 0.01% | 360 |
|
|
2015
Q3 | $2.18M | Buy |
38,164
+2,141
| +6% | +$122K | 0.04% | 182 |
|
|
2015
Q2 | $3.25M | Buy |
36,023
+5,047
| +16% | +$456K | 0.06% | 160 |
|
|
2015
Q1 | $2.98M | Sell |
30,976
-3,524
| -10% | -$339K | 0.05% | 167 |
|
|
2014
Q4 | $3.02M | Sell |
34,500
-1,186
| -3% | -$104K | 0.06% | 165 |
|
|
2014
Q3 | $3.26M | Sell |
35,686
-286
| -0.8% | -$26.1K | 0.06% | 163 |
|
|
2014
Q2 | $4.14M | Buy |
35,972
+365
| +1% | +$42K | 0.08% | 143 |
|
|
2014
Q1 | $4.31M | Buy |
35,607
+7,525
| +27% | +$912K | 0.08% | 134 |
|
|
2013
Q4 | $3.53M | Buy |
28,082
+3,487
| +14% | +$438K | 0.07% | 131 |
|
|
2013
Q3 | $2.68M | Buy |
24,595
+3,968
| +19% | +$432K | 0.06% | 148 |
|
|
2013
Q2 | $1.74M | Buy |
+20,627
| New | +$1.74M | 0.04% | 156 |
|